Clinical trial logistics

Concomitant Medication Procurement for Clinical Trials

Licensed concomitant medication procurement, controlled storage and clinical-site distribution for clinical trials in Türkiye.

IMPinvestigational product
IVDkits and reagents
MDmedical devices
End-to-endoperating model

Clinical medication sourcing

Trace protocol-aligned medicine from source to site

01

Local sourcing against the approved product specification

Receive active ingredient, strength, form, pack and alternative rules. Client-facing output: Source and product options.

02

Supplier and product/lot evidence review

Search only authorised and verifiable channels. Client-facing output: Purchase and lot receipt record.

03

Purchase, receipt and controlled storage

Submit brand, pack, shelf life, price and availability before purchase. Client-facing output: Inventory and expiry report.

04

Site allocation and proof of delivery

Record product, lot, quantity, expiry, pack and evidence. Client-facing output: Site delivery and close-out records.

Short answer

What does this service actually solve?

Under its licensed pharmaceutical wholesale operation, Omega Depot sources protocol-defined concomitant medication from authorised local channels and manages lot receipt, controlled storage, site distribution and accountability.

Procurement brief

Concomitant Medication Procurement for Clinical Trials

Concomitant medication procurement aligns protocol-permitted treatments with a verified product and source through purchase, receipt, storage, site delivery and accountability.

Included in scope

  • Local sourcing against the approved product specification
  • Supplier and product/lot evidence review
  • Purchase, receipt and controlled storage
  • Site allocation and proof of delivery
  • Inventory, expiry, return and close-out tracking

Outside scope

  • Medical treatment selection for the sponsor
  • Protocol or prescribing decisions
  • Availability or price guarantees
  • Controlled products outside written scope
01

Inputs we need

  • Protocol/pharmacy manual and specification
  • Active ingredient, dosage form, strength and forecast quantity
  • Site and target-date plan
  • Alternative product and brand approval rule
02

Records delivered

  • Source and product options
  • Purchase and lot receipt record
  • Inventory and expiry report
  • Site delivery and close-out records
03

Risks affecting timing

  • Market availability changes
  • Unapproved brand or pack differences
  • Shelf life not covering study demand

RACI

Decision and record ownership

Sponsor/medical teamTreatment selection, protocol fit and alternative approval
CRO/study teamSite plan, forecast and approved requests
Omega DepotLicensed sourcing, receipt, storage, distribution and records
SiteReceipt, local accountability and return

Exception scenarios

Keep control when the plan changes

Approved brand is unavailable

Offer ingredient/form/strength-aligned options; never substitute without approval.

Shelf life is insufficient

Plan staged purchase, reorder point or approved alternative.

Product has a special control regime

Verify licence and legal scope before using the standard flow.

Operating model

From uncertainty to a traceable outcome

Every project follows the same control logic, adapted to product and protocol requirements.

  1. 01

    Clinical specification

    Receive active ingredient, strength, form, pack and alternative rules.

  2. 02

    Source qualification

    Search only authorised and verifiable channels.

  3. 03

    Sponsor approval

    Submit brand, pack, shelf life, price and availability before purchase.

  4. 04

    Purchase and receipt

    Record product, lot, quantity, expiry, pack and evidence.

  5. 05

    Storage and inventory

    Maintain manufacturer condition, status and lot traceability.

  6. 06

    Site distribution

    Dispatch against approved request, site and quantity.

  7. 07

    Close-out

    Reconcile return, remainder and destruction instruction.

Service-specific FAQ

What to know before scoping

Does Omega clinically select the medicine?

No. Omega presents verifiable options; the sponsor medical authority selects treatment.

Can a generic or different brand be purchased?

Only under the sponsor-defined equivalence and written approval rule.

Are price and availability guaranteed?

No. Local market conditions are verified at quotation and purchase.

Can products ship directly to sites?

Distribution can follow verification of site, request, storage and delivery conditions.

What happens to returned medication?

It is quarantined for reconciliation, authorised reassessment or destruction.

Omega Depot

Plan your next shipment with confidence

Share the product, route and timeline; our team will map a workable operational flow.

Talk to our team